Inhibidor de la tirosina quinasa (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibidor de la tirosina quinasa" in Spanish language version.

refsWebsite

Global rank Spanish rank

4^th place

4^th place

3web.archive.org

1^st place

1^st place

1aacrjournals.org

8,869^th place

4,719^th place

2^nd place

2^nd place

low place

low place

1,684^th place

1,021^st place

1fibrosispulmonaridiopatica.blogspot.com

low place

5,564^th place

1biomedcentral.com

2,747^th place

1,053^rd place

1bloodjournal.org

low place

low place

low place

low place

aacrjournals.org

cancerres.aacrjournals.org

Zhao Y, Thomas HD, Batey MA, et al. (mayo de 2006). «Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441». Cancer Res. 66 (10): 5354-62. PMID 16707462. doi:10.1158/0008-5472.CAN-05-4275.

ajmc.com

Emerging Options May Help Address Challenges With Traditional BTK-Inhibitor Treatment in Lymphomas

biomedcentral.com

jhoonline.biomedcentral.com

Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor, Jingjing Wu, Mingzhi Zhang & Delong Liu; Journal of Hematology & Oncology; DOI: 10.1186/s13045-016-0250-9, 9 March 2016

bloodjournal.org

Walter HS, Rule SA, Dyer MJS, Karlin L, Jones C, Cazin B, et al. A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies. Blood. 2016;127(4):411–9.

cancer.gov

«Definition of tyrosine kinase inhibitor - NCI Dictionary of Cancer Terms». Archivado desde el original el 11 de mayo de 2008.

doi.org

dx.doi.org

Zhao Y, Thomas HD, Batey MA, et al. (mayo de 2006). «Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441». Cancer Res. 66 (10): 5354-62. PMID 16707462. doi:10.1158/0008-5472.CAN-05-4275.

fibrosispulmonaridiopatica.blogspot.com

Rondón, Carlos (19 de diciembre de 2011). «Inhibidores de la tirosina quinasa, una esperanza prometedora.».

nih.gov

pubchem.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

Zhao Y, Thomas HD, Batey MA, et al. (mayo de 2006). «Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441». Cancer Res. 66 (10): 5354-62. PMID 16707462. doi:10.1158/0008-5472.CAN-05-4275.
Na L, Zhijian S, Ye L, Mingming G, Yilu Z, Dongping Z, et al. Abstract 2597: BGB-3111 is a novel and highly selective Bruton’s tyrosine kinase (BTK) inhibitor. Cancer Res. 2015;75:2597

plexxikon.com

«Plexxikon Initiates Phase 1 Trial for PLX5568». Archivado desde el original el 12 de junio de 2009.

web.archive.org

«Plexxikon Initiates Phase 1 Trial for PLX5568». Archivado desde el original el 12 de junio de 2009.
«Definition of tyrosine kinase inhibitor - NCI Dictionary of Cancer Terms». Archivado desde el original el 11 de mayo de 2008.
https://web.archive.org/web/20100121200323/http://www.nature.com/nrd/journal/v8/n9/full/nrd2871.html "Factors underlying sensitivity of cancers to small-molecule kinase inhibitors"